Princeton, NJ -- (SBWIRE) -- 05/31/2018 -- Global hemostats market is projected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.

Explore more info about this report @ https://www.researchcosmos.com/reports/hemostast-market-analysis-global-industry-outlook-and-forecast-2017-to-2024/1608028118

The global hemostats market is segmented on the basis of type, application, distribution channel, and end user.

The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats.

On the basis of application, the market is segmented into surgery and wound closure.

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Based on geography, the global hemostats market is segmented into 5 geographical regions such as:
North America
South America
Europe
APAC
MEA
Rest Of the World

Request for Sample @ https://www.researchcosmos.com/request/1608028118

Global hemostats market competition by top players including:
1) Ethicon US LLC
2) Pfizer
3) Baxter
4) Vascular Solutions, Inc
5) B.Braun Melsungen
6) 3-D Matrix, Ltd
7) Anika Therapeutics, Inc

Ask For Customization @ https://www.researchcosmos.com/customization/1608028118

About Us:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We're associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

Contact Us:
Kevin Stewart
Sales Manager
Research Cosmos
www.researchcosmos.com
kevin@researchcosmos.com
Phone: +1 888 709 8757